Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05823740 · ClinicalTrials.gov registry record · NA
Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
A NA study of Cancer and Malignant Neoplasm, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT05823740: Active NA study of Cancer and Malignant Neoplasm, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT05823740 is a NA study of Cancer and Malignant Neoplasm that is active but no longer recruiting, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 28 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05823740, a NA study of Cancer and Malignant Neoplasm, is active but no longer recruiting, sponsored by UNC Lineberger Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to evaluate the feasibility and acceptability of obtaining repeated measurements of lean muscle mass, physical function, and biological aging in children receiving active cancer therapy. The secondary objective is to evaluate the feasibility of using the D3-creatine dilution method (D3Cr) to measure skeletal muscle mass in children with cancer. Assessments will be collected at diagnosis, once during active treatment, and end of treatment in coordination with routine imaging to monitor changes in study outcomes during active cancer treatment. Key sociodemographic, treatment and health-related factors will be abstracted from the medical record.
Primary Outcome
The feasibility of collecting body composition assessments will be measured as the % of participants completing all 3 assessments for each modality: D3-Creatine dilution method (D3Cr), Bioelectrical impedance Analysis (BIA), medical imaging (computerized tomography (CT), or magnetic resonance imaging (MRI), or positron emission tomography (PET).
Conditions Studied
Interventions
- OTHER Bioelectrical impedance Analysis (BIA)
- OTHER D3-Creatine Dilution (D3Cr)
- OTHER 6-Minute Walk Test (6MWT)
- OTHER Timed Up and Go (TUG)
- OTHER 30-second Sit-to-Stand (STS)
Study Locations (1)
North Carolina
- UNC Lineberger Comprehensive Cancer Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT05823740 still lists
NCT05823740 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 5 interventions - of which Bioelectrical impedance Analysis (BIA) is the first listed.
NCT05823740 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05823740 about?
NCT05823740 is a clinical study titled "Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers". The primary objective of this study is to evaluate the feasibility and acceptability of obtaining repeated measurements of lean muscle mass, physical function, and biological aging in children receiving active cancer therapy. The secondary objective is to evaluate the feasibility of using the D3-cre...
What is the current status of trial NCT05823740?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2023-05-01. Estimated completion is 2026-03-31.
What conditions does trial NCT05823740 study?
This clinical trial studies the following conditions: Cancer, Malignant Neoplasm.
What interventions are being tested in trial NCT05823740?
The interventions under investigation include: Bioelectrical impedance Analysis (BIA) (OTHER), D3-Creatine Dilution (D3Cr) (OTHER), 6-Minute Walk Test (6MWT) (OTHER), Timed Up and Go (TUG) (OTHER), 30-second Sit-to-Stand (STS) (OTHER).
Who is sponsoring clinical trial NCT05823740?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05823740 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05823740's enrollment target sits among peer trials
28 528th of 615 higher than 87 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI